Clinical Trial Update: ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in metastatic colorectal cancer evaluating ctDNA-guided treatment combining a tyrosine kinase inhibitor with a PD-1 inhibitor; currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING